Purple biotech reports second quarter 2022 financial results

Rehovot, israel, aug. 04, 2022 (globe newswire) -- purple biotech ltd. ("purple biotech", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by harnessing the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the second quarter ended june 30, 2022.
PPBT Ratings Summary
PPBT Quant Ranking